Skip to main content
Quest Diagnostics

US HIV-1 Drug Resistance Trends in the Era of Modern ARV Regimens From 2018–2024

CROI 2025

Conference on Retroviruses and Opportunistic Infections

San Francisco, CA, Mar 9-12 , 2025

Poster presentation: US HIV-1 Drug Resistance Trends in the Era of Modern ARV Regimens From 2018–2024

Authors: Kagan RM, Baxter JD, Kim T and  Marlowe EM

Specialty: Infectious disease

Related content

Conference Presentation
HIV Drug Resistance Testing for Contemporary ART
Publication
Insights into HIV-1 transmission dynamics using routinely collected data in the Mid-Atlantic United States
Test FAQ
HIV 1 Resistance Proviral DNA RTI PI Integrase Inhibitors
Test FAQ
HIV-1 Integrase Genotype
Test FAQ
HIV-1 Coreceptor Tropism Proviral DNA

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.